Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Next generation of immunotherapy for melanoma
John M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma
Ahmad A Tarhini, John Cherian, Stergios J Moschos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2004
Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency
Jean L Chan, Stergios J Moschos, John Bullen, et al.
Annals of Surgical Oncology
|
June 26, 2026
Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients
Kristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Journal of Computer Assisted Tomography
|
September 17, 2016
Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma
Ana Marija Franceschi, Stergios J Moschos, Carey K Anders, et al.
Melanoma Research
|
May 17, 2007
Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents
Stergios J Moschos, Christine Odoux, Stephanie R Land, et al.
Annals of Surgical Oncology
|
July 3, 2026
ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients
Kristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M Kirkwood, Sandra Lee, Stergios J Moschos, et al.
NPJ Genomic Medicine
|
August 17, 2021
Multiregional genetic evolution of metastatic uveal melanoma
Daniel A Rodriguez, Jessica Yang, Michael A Durante, et al.
Melanoma Research
|
May 11, 2017
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma
Ahmad A Tarhini, Stergios J Moschos, Yan Lin, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Next generation of immunotherapy for melanoma
John M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2011
Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma
Ahmad A Tarhini, John Cherian, Stergios J Moschos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2004
Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency
Jean L Chan, Stergios J Moschos, John Bullen, et al.
Annals of Surgical Oncology
|
June 26, 2026
Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients
Kristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Journal of Computer Assisted Tomography
|
September 17, 2016
Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma
Ana Marija Franceschi, Stergios J Moschos, Carey K Anders, et al.
Melanoma Research
|
May 17, 2007
Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents
Stergios J Moschos, Christine Odoux, Stephanie R Land, et al.
Annals of Surgical Oncology
|
July 3, 2026
ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients
Kristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M Kirkwood, Sandra Lee, Stergios J Moschos, et al.
NPJ Genomic Medicine
|
August 17, 2021
Multiregional genetic evolution of metastatic uveal melanoma
Daniel A Rodriguez, Jessica Yang, Michael A Durante, et al.
Melanoma Research
|
May 11, 2017
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma
Ahmad A Tarhini, Stergios J Moschos, Yan Lin, et al.
Page
of 9